XML 18 R7.htm IDEA: XBRL DOCUMENT v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash flows from operating activities:    
Net loss $ (6,343) $ (128,362)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Depreciation, depletion, and amortization 35,660 21,258
Amortization of debt issuance costs 1,511 527
Loss on extinguishment of debt 316 0
Share-based compensation expense 2,262 126,895
Loss on derivative instruments 65,134 37,218
Cash paid on settlement of derivative instruments (17,992) (3,585)
Non-cash lease expense 72 80
Deferred income taxes (353) 35
Changes in operating assets and liabilities:    
Accounts receivable (17,674) 22,013
Prepaid expenses and other assets (4,635) (1,151)
Accounts payable (13,697) (978)
Royalties payable 6,463 3,319
Accrued and other expenses 7,812 (4,707)
Other assets and liabilities (109) 1,667
Net cash provided by operating activities 58,427 74,229
Cash flows from investing activities:    
Additions to oil and gas properties (75,570) (105,665)
Acquisitions of oil and gas properties and midstream assets (622,534) 0
Additions to midstream and other property and equipment (808) (2,766)
Net cash used in investing activities (698,912) (108,431)
Cash flows from financing activities:    
Borrowings under revolving credit facility 430,530 56,000
Payments on revolving credit facility (581,376) (304,000)
Proceeds from issuance of Notes 550,000 0
Proceeds from issuance of Class A common stock in initial public offering, net of underwriting discounts and commissions 0 286,465
Proceeds from issuance of Series A preferred stock 350,000 0
Payments of credit facility debt issuance costs (13,257) (645)
Payments of Notes debt issuance costs (9,626) 0
Cancelled shares withheld for taxes from vesting of RSUs (1,201) 0
Payments on notes payable (55) (37)
Net cash provided by financing activities 710,619 36,858
Net increase in cash and cash equivalents 70,134 2,656
Cash and cash equivalents at beginning of period 2,849 2,203
Cash and cash equivalents at end of period 72,983 4,859
Series A Preferred Stock    
Cash flows from financing activities:    
Payments of stock issuance costs (14,396) 0
Common Stock    
Cash flows from financing activities:    
Payments of stock issuance costs $ 0 $ (925)